Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RNU4-90P (RNA, U4 small nuclear 90, pseudogene)** is a *pseudogene* derived from the sequence of the U4 small nuclear RNA (snRNA), a component of the spliceosome machinery in human cells[1]. This pseudogene contains sequence similarity to the functional U4 snRNA gene but has accumulated mutations and structural features—such as perfect direct repeats flanking the sequence—that are hallmarks of processed RNA pseudogenes and suggest a reverse transcription/integration origin[1]. RNU4-90P is not a protein-coding gene, nor is it known to produce a functional RNA product; like other pseudogenes, it is considered genomically inactive and does not encode a functional receptor, enzyme, transporter, or other druggable molecular target[1]. No disease roles, molecular functions, or drug interactions have been documented for RNU4-90P. Because it is a pseudogene, **RNU4-90P is not considered a therapeutic target or biologically functional molecule**; therefore, most structured fields (functions, diseases, drugs, etc.) are not applicable[1]. The entry is “incorrect” as a biomedical target due to its pseudogene status.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U4 small nuclear 90, pseudogene (RNU4-90P).